首页 | 本学科首页   官方微博 | 高级检索  
     检索      

欧盟REACH法案对我国医药行业的影响和启示
引用本文:廖淑雯,陈永法,邵蓉.欧盟REACH法案对我国医药行业的影响和启示[J].中国医药技术经济与管理,2009,3(8):86-90.
作者姓名:廖淑雯  陈永法  邵蓉
作者单位:中国药科大学国际医药商学院,江苏,南京,211198
摘    要:目的 探讨欧盟REACH法案对我国医药行业产生的影响和应对策略。方法通过研究REACH法案的主要内容、目标和采取的手段,分析哪些医药产品在REACH法案的管制范围之内,以及它会产生何种程度的影响。结果和结论目前REACH法案对我国医药行业的影响还是有限的,但我们仍应密切关注其发展动态,随时做好应对的准备,同时不断完善我国相应的法规和制度.

关 键 词:医药行业  欧盟  医药产品

The Impact and Inspirations of EU REACH Bill on China's Pharmaceutical Industry
LIAO Shuwen,CHEN Yongfa,SHAO Rong.The Impact and Inspirations of EU REACH Bill on China's Pharmaceutical Industry[J].Chinese Journal of Pharmacentical Technolgy Economics & Management,2009,3(8):86-90.
Authors:LIAO Shuwen  CHEN Yongfa  SHAO Rong
Institution:(International Busines School of China Pharmaceutical University,Nanjing,211198,China)
Abstract:Objective To explore the impact of EU REACH bill on China' s pharmaceutical industry and how to reply to it. Methods Through studying the main elements and objectives of REACH, this thesis has analyzed which medical products would be regulated by REACH as well as the impact degree which it would have. Results and Conclusions At present, the impact of REACH on China' s pharmaceutical industry is still limited. But we should still pay close attention to its development, meanwhile continually improve our relevant laws and regulations, so as to reply to it naturally.
Keywords:REACH
本文献已被 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号